[Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].

López-Hernández, M A

[Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center]. [electronic resource] - Gaceta medica de Mexico - 145-51 p. digital

Publication Type: Comparative Study; Journal Article

0016-3813


Adolescent
Age Factors
Anti-Inflammatory Agents--therapeutic use
Antibiotics, Antineoplastic--therapeutic use
Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Agents, Alkylating--therapeutic use
Antineoplastic Agents, Hormonal--therapeutic use
Antineoplastic Agents, Phytogenic--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Asparaginase--therapeutic use
Carmustine--therapeutic use
Child
Child, Preschool
Cyclophosphamide--therapeutic use
Cytarabine--therapeutic use
Data Interpretation, Statistical
Disease-Free Survival
Doxorubicin--therapeutic use
Female
Humans
Hydrocortisone--therapeutic use
Male
Mercaptopurine--therapeutic use
Methotrexate--therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prednisone--therapeutic use
Risk Factors
Time Factors
Vincristine--therapeutic use